Acasti Pharma Reports Second Quarter 2023 Operational Results Nov 14, 2022 07:00AM
Acasti Pharma Reports First Quarter 2023 Operational Results Aug 11, 2022 07:00AM
Acasti Pharma to Present at the B. Riley Securities' 2022 Virtual Neuro & Ophthalmology Conference on April 28th Apr 25, 2022 08:30AM
Acasti Pharma Provides Fiscal 2021 Year-End Business Update Jun 22, 2021 07:00AM
Acasti Pharma Provides Update on Recent Financing Activities Mar 8, 2021 05:30PM


Jan 27, 2021 06:55AM Acasti Pharma Provides Update on Recent Financing Activities
Aug 13, 2020 08:30AM Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2021
Jun 29, 2020 09:45AM Acasti Pharma Provides Fiscal 2020 Year-End Business Update
Feb 14, 2020 08:00AM Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2020
Dec 24, 2019 06:08AM Acasti Pharma (ACST) Topline Results for TRILOGY 1 Phase 3 Trial of CaPre Postponed Due to Unexpected Delay in Data Processing and Transfer
Dec 23, 2019 08:31PM Acasti Pharma Provides Update on Timing of Topline Results for TRILOGY 1 Phase 3 Trial of CaPre
May 21, 2019 07:30AM Acasti Pharma to Present at the 20th Annual B. Riley FBR Institutional Investor Conference